Ensuring PCR Quality – Laboratory Organisation, PCR Optimization and Controls

Three distinct levels of quality control should be considered when setting up PCR applications for use in the clinical laboratory. The primary level of quality control involves the organization of the laboratory and relevant logistical aspects, which are areas of major importance with respect to the avoidance of PCR contamination and the prevention of false positive clinical results. The secondary level of quality control involves PCR design, optimization and assay quality control per se. Finally, there may be individual quality considerations that are specifically related to individual types of PCR methodologies (especially reverse transcription PCR methodologies).

Keywords

Hydrolysis Phenol Lymphoma DMSO Heparin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Al Soud WA, Radstrom P. 1998. Capacity of nine thermostable DNA polymerases to mediate amplification in the presence of PCR inhibiting substances. J Environ Microbiol 64:3748–3753.Google Scholar
  2. Al Soud WA, Radstrom P. 2000. Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces and meat. J Clin Microbiol 38:4463–4470.PubMedGoogle Scholar
  3. Al Soud WA, Radstrom P. 2001. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 39(2):485–493.PubMedCrossRefGoogle Scholar
  4. Baldrick E, Xamena N, Cabre O. 1999. Overcoming false negatives due to the genomic context in PCR amplification. J Biochem Biophys Methods 40:45–48.CrossRefGoogle Scholar
  5. Belec L, Authier J, Eliezer-Vanerot MC, Piedouillet C, Mohamed AS, Gherardi RK. 1998. Myoglobin as a PCR inhibitor: a limitation for PCR from skeletal muscle tissue avoided by the use of Thermus thermophilus polymerase. Muscle Nerve 21:1064–1067.PubMedCrossRefGoogle Scholar
  6. Buffone GJ, Demmler GJ, Schimbor CM, Greer J. 1991. Improved amplification of CMV DNA from urine after purification of DNA with glass beads. Clin Chem 37:1945–1949.PubMedGoogle Scholar
  7. Cobb BD, Clarkson JM. 1994. A simple procedure for optimizing the PCR using modified Taguchi methods. Nucleic Acids Res 22:3801–3805.PubMedCrossRefGoogle Scholar
  8. Dakhama A, Maeck V, Hogg JC, Hegele RG. 1996. Amplification of human beta-actin gene by the reverse transcriptase PCR: implications for assessment of RNA from formalin fixed paraffin embedded material. J Histochem Cytochem 44:1205–1207.PubMedGoogle Scholar
  9. Finke J, Fritzen R, Ternes P, Lange W, Dolken G. 1993. An improved strategy and a useful housekeeping gene for RNA analysis from formalin fixed paraffin embedded tissues by PCR. Biotechniques 14:448–453.PubMedGoogle Scholar
  10. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S. 1995. The detection of melanoma cells in peripheral blood by reverse transcription PCR. Br J Cancer 72:155–159.PubMedGoogle Scholar
  11. Golenberg EM, Bickel A, Weihs P. 1996. Effect of highly fragmented DNA on PCR. Nucleic Acids Res 24:5026–5033.PubMedCrossRefGoogle Scholar
  12. Greer CE. 1991. PCR amplification from paraffin-embedded tissues: effect of fixative and fixation time. Am J Clin Pathol 95:117–124.PubMedGoogle Scholar
  13. Jinno Y, Yoshiura K, Niikawa N. 1990. Use of psoralen as extinguisher of contaminated DNA in PCR. Nucleic Acids Res 18:6739.PubMedCrossRefGoogle Scholar
  14. Kang J, Lee MS, Gorenstein DG. 2005. The enhancement of PCR amplification of a random sequence DNA library by DMSO and betaine: application to in vitro combinatorial selection of aptamers. J Biochem Biophys Methods 64(2):147–151.PubMedCrossRefGoogle Scholar
  15. KlaschikS, Lehman LE, Raadts A, Book M, Hoeft A, Stuber F. 1999. Comparison of different decontamination methods for reagents to detect low concentrations of bacterial 16S DNA by real-time PCR. Mol Biotechnol 3:231–242.Google Scholar
  16. Kleter B, Van Doorn LJ, Ter Schegget J, Schrauwen L, Van Krimpen K, Burger M, Ter Harmsel B, Quint W. 1998. Novel short fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 153:1731–1739.PubMedGoogle Scholar
  17. Kofler B, Klausegger A. 1999. Simplified PCR set-up using a frozen preformulated mix for the detection of CMV. Diagn Microbiol Infect Dis 34:33–35.PubMedCrossRefGoogle Scholar
  18. Koopmans M, Monroe SS, Coffield LM, Zaki SR. 1993. Optimization of extraction and PCR amplification of RNA extracts from paraffin embedded tissue in different fixatives. J Virol Methods 43:189–204.PubMedCrossRefGoogle Scholar
  19. Kunakorn M, Raksakai M, Niemhorn S, Chongtrakool P, Pracharktam R. 2002. Overcoming the errors of in-house PCR used in the clinical laboratory for the diagnosis of extra-pulmonary tuberculosis. Southeast Asian J Trop Med Public Health 30:84–90.Google Scholar
  20. Lewis SM. 1995. Quality assurance programmes in the United Kingdom. Ann Ist Super Sanita 31:53–59.PubMedGoogle Scholar
  21. Linssen B, Kinney RM, Aguilar PM, Russell KL, Watts DM, Kaaden O, Pfeffer M. 2000. Development of reverse transcription PCR assays specific for the detection of equine encephalitis viruses. J Clin Microbiol 38:1527–1535.PubMedGoogle Scholar
  22. Matthews JL, Chung M, Matyas RJ. 2002. Persistent DNA contamination in competitive RT-PCR using cRNA internal standards: identity, quantity and control. Biotechniques 32:1412–1417.PubMedGoogle Scholar
  23. Noordhoek GT, Van Embden JD, Kolk AH. 1996. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: and international collaborative quality control study among 30 laboratories. J Clin Microbiol 34:2522–2525.PubMedGoogle Scholar
  24. Ou CY, Moore JL, Schochetman G. 1991. Use of UV irradiation to reduce false positivity in PCR. Biotechniques 10:442–446.PubMedGoogle Scholar
  25. Radonic A, Thulke S, Mackai TM. 2004. Guideline for reference gene selection for quantitative real-time PCR. Biol Bioch Res Commun 313:856–862.CrossRefGoogle Scholar
  26. Rees WA, Yager TD, Korte J, Von Hippel PH. 1993. Betaine can eliminate the base pair composition dependence of DNA melting. Biochem 32:137–144.CrossRefGoogle Scholar
  27. Sellon RK. 2003. Update on molecular techniques for diagnostic testing of infectious diseases. Vet Clin North Am Small Anim Pract 33:677–693.PubMedCrossRefGoogle Scholar
  28. Shlyakhtenko LS, Potaman VN, Sinden RR, Lyubchenko YL. 1998. Structure and dynamics of supercoil stabilized DNA cruciforms. J Mol Biol 280:61–72.PubMedCrossRefGoogle Scholar
  29. Sirko DA, Ehrlich GD. 1994. PCR laboratory facilities, protocols and operations. In: Ehrlich GD, Greenberg SJ (eds) PCR-based diagnostics in infectious disease. Blackwell, Boston, MA, pp. 19–44.Google Scholar
  30. Sonneveld T, Tobutt KR, Robbins TP. 2003. Allele specific PCR detection of sweet cherry self incompatibility (S) alleles S1 to S16 using consensus and allele specific primers. Theor Appl Genet 107:1059–1070.PubMedCrossRefGoogle Scholar
  31. Soukup J, Krskova L, Hilska I, Kodet R. 2003. Ethanol fixation of lymphoma samples as an alternative approach for preservation of the nucleic acids. Neoplasma 50:300–304.PubMedGoogle Scholar
  32. Tournier I, Bernuau D, Poliard A, Schoevaert D, Feldmann G. 1987. Detection of albumin mRNAs in rat liver by in situ hybridization: usefulness of paraffin embedding and comparison of various fixation procedures. J Histochem Cytochem 35:453–459.PubMedGoogle Scholar
  33. Tzanakaki G, Tsolia M, Vlachou V, Theodoridou M, Pangalis A, Foustoukou M, Karpathios T, Blackwell CC, Kremastinou J. 2003. Evaluation of non-culture diagnosis of invasive meningococcal disease by PCR. FEMS Immunol Med Microbiol 39:31–36.PubMedCrossRefGoogle Scholar
  34. Van Belkum A, Scherer S, Van Alphen L, Verbrugh H. 1998. Short sequence DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev 62:275–293.PubMedGoogle Scholar
  35. Van den Brule A, Claas ECJ, Du Maine M, Melchers WJ, Helmerhorst T, Quint WG, Lindeman J, Meijer CJ, Walboomers J. 1989. Use of anti-contamination primers in the PCR for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J Med Virol 29:20–27.PubMedCrossRefGoogle Scholar
  36. Wallace PS. 2003. Linkage between the journal and the Quality Control Molecular Diagnostics (QCMD). J Clin Virol 27:211–212.PubMedCrossRefGoogle Scholar
  37. Wiedbrauk DL, Werner JC, Drevon AM. 1995. Inhibition of PCR by aqueous and vitreous fluids. J Clin Microbiol 33:2643–2646.PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media B.V 2008

Personalised recommendations